RHL Group’s Eli Lilly LLY Stock Holding History

RHL Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$165K	Buy	138 +6	+5%	+$6.13K	0.14%	37
2026 Q1	$122K	Buy	132 +42	+47%	+$42.6K	0.1%	38
2025 Q4	$96.7K	Buy	+90	New	+$86.1K	0.08%	50

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RHL Group's LLY Position: Q2 2026 in Review

RHL Group increased its Eli Lilly (LLY) stake by 4.5% in Q2 2026, buying an estimated $6.13K and bringing the position to 138 shares worth $165K. The position accounts for 0.14% of the portfolio, ranked #37.

RHL Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

RHL Group held 138 shares of Eli Lilly worth $165K as of Q2 2026.
RHL Group bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
Eli Lilly made up 0.14% of RHL Group's portfolio in Q2 2026, its #37 holding.
RHL Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on RHL Group's 13F filing for Q2 2026, filed 4 Aug 2026.